MX2009001020A - Proceso quimico para preparacion de esteres y amidas de ciclopropano aromaticos. - Google Patents
Proceso quimico para preparacion de esteres y amidas de ciclopropano aromaticos.Info
- Publication number
- MX2009001020A MX2009001020A MX2009001020A MX2009001020A MX2009001020A MX 2009001020 A MX2009001020 A MX 2009001020A MX 2009001020 A MX2009001020 A MX 2009001020A MX 2009001020 A MX2009001020 A MX 2009001020A MX 2009001020 A MX2009001020 A MX 2009001020A
- Authority
- MX
- Mexico
- Prior art keywords
- compound
- formula
- preparing
- base
- preparation
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract description 11
- -1 aromatic cyclopropane esters Chemical class 0.000 title description 5
- 238000001311 chemical methods and process Methods 0.000 title description 2
- 150000001408 amides Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 43
- 238000000034 method Methods 0.000 claims abstract description 16
- 230000008569 process Effects 0.000 claims abstract description 15
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 8
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical group [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 6
- GGUBFICZYGKNTD-UHFFFAOYSA-N triethyl phosphonoacetate Chemical compound CCOC(=O)CP(=O)(OCC)OCC GGUBFICZYGKNTD-UHFFFAOYSA-N 0.000 claims description 6
- 229910021529 ammonia Inorganic materials 0.000 claims description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 4
- 239000012312 sodium hydride Substances 0.000 claims description 4
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical group [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 claims description 2
- FCSKOFQQCWLGMV-UHFFFAOYSA-N 5-{5-[2-chloro-4-(4,5-dihydro-1,3-oxazol-2-yl)phenoxy]pentyl}-3-methylisoxazole Chemical compound O1N=C(C)C=C1CCCCCOC1=CC=C(C=2OCCN=2)C=C1Cl FCSKOFQQCWLGMV-UHFFFAOYSA-N 0.000 claims 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims 1
- 239000000543 intermediate Substances 0.000 abstract description 7
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract description 2
- 239000012450 pharmaceutical intermediate Substances 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 39
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000002585 base Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- VMEDAWUIKFAFJQ-UHFFFAOYSA-N 2-chloro-1-(3,4-difluorophenyl)ethanone Chemical compound FC1=CC=C(C(=O)CCl)C=C1F VMEDAWUIKFAFJQ-UHFFFAOYSA-N 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 4
- 239000012442 inert solvent Substances 0.000 description 4
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- GOYDNIKZWGIXJT-UHFFFAOYSA-N 1,2-difluorobenzene Chemical compound FC1=CC=CC=C1F GOYDNIKZWGIXJT-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 229940126062 Compound A Drugs 0.000 description 2
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical compound [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- AIMMVWOEOZMVMS-UHFFFAOYSA-N cyclopropanecarboxamide Chemical compound NC(=O)C1CC1 AIMMVWOEOZMVMS-UHFFFAOYSA-N 0.000 description 2
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropyl acetate Chemical compound CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- QVUBIQNXHRPJKK-IMTBSYHQSA-N (1r,2s)-2-(3,4-difluorophenyl)cyclopropan-1-amine Chemical compound N[C@@H]1C[C@H]1C1=CC=C(F)C(F)=C1 QVUBIQNXHRPJKK-IMTBSYHQSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- SDTMFDGELKWGFT-UHFFFAOYSA-N 2-methylpropan-2-olate Chemical compound CC(C)(C)[O-] SDTMFDGELKWGFT-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
- 229910004373 HOAc Inorganic materials 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- ZZWBWTXHCRXFML-UHFFFAOYSA-K [Al+3].[Cl-].[Cl-].[Cl-].Fc1ccc(cc1F)C(=O)CCl Chemical compound [Al+3].[Cl-].[Cl-].[Cl-].Fc1ccc(cc1F)C(=O)CCl ZZWBWTXHCRXFML-UHFFFAOYSA-K 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- BDOLXPFAFMNDOK-UHFFFAOYSA-N oxazaborolidine Chemical group B1CCON1 BDOLXPFAFMNDOK-UHFFFAOYSA-N 0.000 description 1
- 230000010118 platelet activation Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- WRECIMRULFAWHA-UHFFFAOYSA-N trimethyl borate Chemical compound COB(OC)OC WRECIMRULFAWHA-UHFFFAOYSA-N 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/24—Preparation of carboxylic acid esters by reacting carboxylic acids or derivatives thereof with a carbon-to-oxygen ether bond, e.g. acetal, tetrahydrofuran
- C07C67/26—Preparation of carboxylic acid esters by reacting carboxylic acids or derivatives thereof with a carbon-to-oxygen ether bond, e.g. acetal, tetrahydrofuran with an oxirane ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/08—Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/58—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
- C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
- C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/40—Halogenated unsaturated alcohols
- C07C33/46—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/753—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring of polycyclic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D301/00—Preparation of oxiranes
- C07D301/02—Synthesis of the oxirane ring
- C07D301/24—Synthesis of the oxirane ring by splitting off HAL—Y from compounds containing the radical HAL—C—C—OY
- C07D301/26—Y being hydrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0615619.4A GB0615619D0 (en) | 2006-08-05 | 2006-08-05 | Chemical process for preparation of intermediates |
| PCT/SE2007/000706 WO2008018822A1 (en) | 2006-08-05 | 2007-08-02 | Chemical process for preparation of aromatic cyclopropane esters and amides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009001020A true MX2009001020A (es) | 2009-02-05 |
Family
ID=37027327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009001020A MX2009001020A (es) | 2006-08-05 | 2007-08-02 | Proceso quimico para preparacion de esteres y amidas de ciclopropano aromaticos. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7863469B2 (OSRAM) |
| EP (1) | EP2049462A4 (OSRAM) |
| JP (1) | JP2010500343A (OSRAM) |
| KR (1) | KR20090045920A (OSRAM) |
| CN (1) | CN101495442A (OSRAM) |
| AR (1) | AR062148A1 (OSRAM) |
| AU (1) | AU2007282181B2 (OSRAM) |
| BR (1) | BRPI0714573A2 (OSRAM) |
| CA (1) | CA2658953A1 (OSRAM) |
| CL (1) | CL2007002267A1 (OSRAM) |
| GB (1) | GB0615619D0 (OSRAM) |
| IL (1) | IL196233A0 (OSRAM) |
| MX (1) | MX2009001020A (OSRAM) |
| MY (1) | MY147871A (OSRAM) |
| TW (1) | TW200812958A (OSRAM) |
| WO (1) | WO2008018822A1 (OSRAM) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0615620D0 (en) | 2006-08-05 | 2006-09-13 | Astrazeneca Ab | A process for the preparation of optically active intermediates |
| GB0615619D0 (en) * | 2006-08-05 | 2006-09-13 | Astrazeneca Ab | Chemical process for preparation of intermediates |
| ES2558843T3 (es) | 2008-09-09 | 2016-02-09 | Astrazeneca Ab | Procedimiento para preparar [1S-[1-alfa,2-alfa,3-beta(1S*,2R*),5-beta]]-3-[7-[2-(3,4-difluorofenil)-ciclopropilamino]-5-(propiltio)-3H-1,2,3-triazolo[4,5-d]pirimidin-3-il]-5-(2-hidroxietoxi)ciclopentano-1,2-diol y a sus productos intermedios |
| HRP20151325T1 (hr) * | 2009-01-23 | 2016-01-01 | Rigel Pharmaceuticals, Inc. | Pripravci i postupci za inhibiciju jak puta |
| CA2796504A1 (en) | 2010-04-20 | 2011-10-27 | Actavis Group Ptc Ehf | Novel process for preparing phenylcyclopropylamine derivatives using novel intermediates |
| RU2013103794A (ru) | 2010-06-30 | 2014-08-10 | Актавис Груп Птс Ехф | Новые способы получения производных фенилциклопропиламина и их применение для получения тикагрелора |
| WO2012063126A2 (en) | 2010-11-09 | 2012-05-18 | Actavis Group Ptc Ehf | Improved processes for preparing pure (3ar,4s,6r,6as)-6-amino-2,2-dimethyltetrahdro-3ah-cyclopenta[d] [1,3]-dioxol-4-ol and its key starting material |
| JP2014501756A (ja) | 2010-12-20 | 2014-01-23 | アクタビス・グループ・ピーティーシー・イーエイチエフ | トリアゾロ［４，５−ｄ］ピリミジン誘導体及びその中間体の新規調整方法 |
| WO2012172426A1 (en) | 2011-06-15 | 2012-12-20 | Actavis Group Ptc Ehf | Improved process for preparing cyclopentylamine derivatives and intermediates thereof |
| EP2589587A1 (en) | 2011-11-04 | 2013-05-08 | Chemo Ibérica, S.A. | Synthesis of nitrogen substituted cyclopropanes |
| EP2628721A1 (en) | 2012-02-20 | 2013-08-21 | LEK Pharmaceuticals d.d. | Synthesis of 2-(3,4-difluorophenyl)cyclopropanecarboxylic acid |
| EP2644590A1 (en) | 2012-03-30 | 2013-10-02 | LEK Pharmaceuticals d.d. | Synthesis of 2-(3,4-difluorophenyl)cyclopropanamine derivatives and salts |
| WO2013144295A1 (en) | 2012-03-30 | 2013-10-03 | Sandoz Ag | Synthesis of 2-(3,4-difluorophenyl)cyclopropanamine derivatives and salts |
| EP2834247A4 (en) | 2012-04-05 | 2016-03-30 | Reddys Lab Ltd Dr | PREPARATION OF TICAGRELOR |
| CN102775314A (zh) * | 2012-08-03 | 2012-11-14 | 江苏富泽药业有限公司 | 一种反式-（1r,2s）-2-(3,4-二氟苯基)环丙胺的制备方法 |
| CN103664697B (zh) * | 2012-09-07 | 2016-12-21 | 博瑞生物医药（苏州）股份有限公司 | 用于制备芳香族环丙腈及环丙胺的化学方法 |
| CN102863341B (zh) * | 2012-10-22 | 2014-05-07 | 南通大学 | 一种（1r,2s）-2-芳基环丙胺衍生物的化学合成方法 |
| CN103087011A (zh) * | 2013-02-04 | 2013-05-08 | 北京科技大学 | 一种水解动力学拆分制备(s)-3,4-二氟苯基环氧乙烷的方法 |
| CN103073525B (zh) * | 2013-02-04 | 2015-01-28 | 北京科技大学 | 一种合成制备(s)-(3,4-二氟苯基)环氧己烷的方法 |
| WO2014206187A1 (zh) | 2013-06-24 | 2014-12-31 | 苏州明锐医药科技有限公司 | 替卡格雷及其中间体的制备方法 |
| CN104974017B (zh) * | 2014-04-09 | 2017-11-17 | 上海医药工业研究院 | (1r,2s)‑2‑(3,4‑二氟苯基)环丙胺·d‑扁桃酸盐的制备方法 |
| WO2015162630A1 (en) | 2014-04-25 | 2015-10-29 | Anlon Chemical Research Organization | Novel processes for preparing triazolo [4,5-d]- pyrimidines, including ticagrelor, vianew intermediates and new route of synthesis. |
| PT3154959T (pt) | 2014-05-15 | 2019-09-24 | Array Biopharma Inc | 1-((3s,4r)-4-(3-fluorofenil)-1-(2-metoxietil)-pirrolidin-3-il)-3-(4-metil-3-(2-metilpirimidin-5-il)-1-fenil-1h-pirazol-5-il)ureia como inibidor da cinase trka |
| US10011605B2 (en) | 2014-06-18 | 2018-07-03 | Flamma Spa | Process for the preparation of triazolo[4,5-D] pyrimidine cyclopentane compounds |
| CN104326922B (zh) * | 2014-11-03 | 2016-08-17 | 成都百裕制药股份有限公司 | 替格瑞洛中间体(1r,2s)-2-(2,3-二氟苯基)环丙胺的制备方法 |
| TWI579259B (zh) * | 2014-12-17 | 2017-04-21 | 日名國際藥品有限公司 | 製備（１ｒ，２ｓ）－２－（３，４－二氟苯基）－３－ｒ取代－環丙胺的方法 |
| WO2016116942A1 (en) | 2015-01-20 | 2016-07-28 | Anlon Chemical Research Organization | Novel pharmaceutical compounds comprising ticagrelor with salts of aspirin |
| CN105671099A (zh) * | 2016-01-26 | 2016-06-15 | 中国科学院成都生物研究所 | 一种制备光学纯二氟苯基环氧乙烷的方法 |
| CN106854158B (zh) * | 2016-12-08 | 2019-06-14 | 淮阴工学院 | 一种替格瑞洛中间体的合成方法及其中间体 |
| CN106905182A (zh) * | 2017-01-12 | 2017-06-30 | 淮阴工学院 | 一种替格瑞洛中间体的合成方法及其中间体 |
| CN107118141B (zh) * | 2017-04-18 | 2018-11-30 | 淮阴工学院 | 一种替格瑞洛中间体的合成方法及其中间体 |
| CN107686447A (zh) * | 2017-08-25 | 2018-02-13 | 许昌恒生制药有限公司 | 一种替格瑞洛中间体的制备方法 |
| CN108083997A (zh) * | 2017-11-14 | 2018-05-29 | 南通常佑药业科技有限公司 | 一种手性芳基环丙胺衍生物的制备方法 |
| EP3617181A1 (en) | 2018-08-30 | 2020-03-04 | Arevipharma GmbH | Synthesis of trans-2-phenylcyclopropylamine or a salt or solvate thereof |
| CN110437092B (zh) * | 2019-07-11 | 2022-06-10 | 泓博智源(开原)药业有限公司 | 一种替格瑞洛关键中间体芳族环丙烷酰胺的制备方法 |
| CN111233673B (zh) * | 2020-02-26 | 2022-08-16 | 苏州元兴生物医药有限公司 | 一种手性芳香族环丙胺及其盐的制备方法及所用中间体 |
| CN115894496B (zh) * | 2021-09-30 | 2025-03-21 | 上海贝美医药科技有限公司 | 一种替格瑞洛及其中间体的制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4411925A (en) | 1980-01-21 | 1983-10-25 | Pfizer Inc. | Branched amides of L-aspartyl-d-amino acid dipeptides |
| US4590292A (en) | 1985-06-10 | 1986-05-20 | Ciba-Geigy Corporation | Process for the manufacture of cyclopropylamine |
| DE3546372A1 (de) * | 1985-12-31 | 1987-07-02 | Basf Ag | Neue phenylacetaldehyde und verfahren zur herstellung von phenylacetaldehyden |
| DE3729226A1 (de) * | 1987-09-02 | 1989-03-23 | Basf Ag | Verfahren zur herstellung von phenylsubstituierten epoxiden |
| DE3909142A1 (de) | 1989-03-21 | 1990-10-04 | Basf Ag | Verfahren zur herstellung von aminen |
| EP0611826B1 (en) * | 1993-02-15 | 2003-05-02 | Daicel Chemical Industries, Ltd. | Processes for production of optically active epoxides |
| DE4315623A1 (de) | 1993-05-11 | 1994-11-17 | Hoechst Ag | Verfahren zur Herstellung von Aminen |
| DE4400328A1 (de) * | 1994-01-07 | 1995-07-13 | Huels Chemische Werke Ag | Verfahren zur Herstellung von Cyclopropancarbonsäureamid |
| DE19523868A1 (de) | 1995-06-30 | 1997-01-02 | Huels Chemische Werke Ag | Verfahren zur Herstellung von Cyclopropanamin |
| DE19547635A1 (de) * | 1995-12-20 | 1997-06-26 | Bayer Ag | Verfahren zur Herstellung von Cyclopropancarbonsäureamiden |
| GB0013488D0 (en) * | 2000-06-02 | 2000-07-26 | Astrazeneca Ab | Chemical compound |
| AR028110A1 (es) * | 2000-06-02 | 2003-04-23 | Astrazeneca Ab | Nuevo proceso |
| US6552217B2 (en) | 2000-08-01 | 2003-04-22 | Eastman Chemical Company | Process for the preparation of alkyl 1-methylcyclopropanecarboxylate |
| US6683216B1 (en) | 2002-11-06 | 2004-01-27 | Eastman Chemical Company | Continuous process for the preparation of amines |
| GB0615619D0 (en) * | 2006-08-05 | 2006-09-13 | Astrazeneca Ab | Chemical process for preparation of intermediates |
| GB0615620D0 (en) * | 2006-08-05 | 2006-09-13 | Astrazeneca Ab | A process for the preparation of optically active intermediates |
-
2006
- 2006-08-05 GB GBGB0615619.4A patent/GB0615619D0/en not_active Ceased
-
2007
- 2007-07-27 TW TW096127556A patent/TW200812958A/zh unknown
- 2007-07-30 AR ARP070103364A patent/AR062148A1/es not_active Application Discontinuation
- 2007-08-02 BR BRPI0714573-0A patent/BRPI0714573A2/pt not_active IP Right Cessation
- 2007-08-02 JP JP2009523744A patent/JP2010500343A/ja active Pending
- 2007-08-02 MX MX2009001020A patent/MX2009001020A/es active IP Right Grant
- 2007-08-02 EP EP07794102A patent/EP2049462A4/en not_active Withdrawn
- 2007-08-02 KR KR1020097003039A patent/KR20090045920A/ko not_active Ceased
- 2007-08-02 CA CA002658953A patent/CA2658953A1/en not_active Abandoned
- 2007-08-02 MY MYPI20090411A patent/MY147871A/en unknown
- 2007-08-02 CN CNA2007800287758A patent/CN101495442A/zh active Pending
- 2007-08-02 WO PCT/SE2007/000706 patent/WO2008018822A1/en not_active Ceased
- 2007-08-02 AU AU2007282181A patent/AU2007282181B2/en not_active Ceased
- 2007-08-03 CL CL200702267A patent/CL2007002267A1/es unknown
- 2007-08-03 US US11/833,263 patent/US7863469B2/en not_active Expired - Fee Related
-
2008
- 2008-12-28 IL IL196233A patent/IL196233A0/en unknown
-
2010
- 2010-11-30 US US12/956,133 patent/US20110137056A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0714573A2 (pt) | 2013-06-04 |
| TW200812958A (en) | 2008-03-16 |
| US7863469B2 (en) | 2011-01-04 |
| KR20090045920A (ko) | 2009-05-08 |
| IL196233A0 (en) | 2009-09-22 |
| CA2658953A1 (en) | 2008-02-14 |
| EP2049462A4 (en) | 2012-06-13 |
| US20080132719A1 (en) | 2008-06-05 |
| AU2007282181B2 (en) | 2012-04-19 |
| CL2007002267A1 (es) | 2008-04-04 |
| AR062148A1 (es) | 2008-10-15 |
| JP2010500343A (ja) | 2010-01-07 |
| GB0615619D0 (en) | 2006-09-13 |
| AU2007282181A1 (en) | 2008-02-14 |
| WO2008018822A1 (en) | 2008-02-14 |
| US20110137056A1 (en) | 2011-06-09 |
| EP2049462A1 (en) | 2009-04-22 |
| MY147871A (en) | 2013-01-31 |
| CN101495442A (zh) | 2009-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009001020A (es) | Proceso quimico para preparacion de esteres y amidas de ciclopropano aromaticos. | |
| US11702380B2 (en) | Synthesis of omecamtiv mecarbil | |
| US8877931B2 (en) | Process and intermediates for preparing integrase inhibitors | |
| AU2018102141A4 (en) | Method for preparing Baricitinib | |
| CN107417505A (zh) | α‑卤代四甲基环己酮及其与（2,3,4,4‑四甲基环戊基）甲基羧酸酯的制备方法 | |
| TWI294426B (en) | Process for the preparation of ccr-2 antagonist | |
| TW201040152A (en) | Method for preparing ascorbic acid derivatives | |
| EP1753770B1 (en) | A process for the synthesis of terbinafine and derivatives thereof | |
| CN101712584B (zh) | α，β，γ，δ-不饱和羰基化合物的合成方法 | |
| WO2003014067A1 (fr) | Methode de production d'un compose beta-oxonitrile ou d'un sel de metal alcalin dudit compose | |
| JP4451537B2 (ja) | 置換脂環式−１，３−ジオンの製造方法 | |
| JP4380160B2 (ja) | ７−キノリニル−３，５−ジヒドロキシヘプト−６−エン酸エステルの製造法 | |
| AU2012201783A1 (en) | Chemical process for preparation of aromatic cyclopropane esters and amides | |
| RU2389726C2 (ru) | СПОСОБ ПОЛУЧЕНИЯ 2-АЛКИЛ-5,6,7,8,9,10-ГЕКСАГИДРО-4Н-ЦИКЛОНОНА[b]СЕЛЕНОФЕНОВ | |
| JP4366854B2 (ja) | １２−アミノ−４，８−ドデカジエンニトリル及びその製造法 | |
| JP3743867B2 (ja) | ２−フルオロシクロプロパンカルボン酸類の製造法 | |
| CN107721796B (zh) | 一种含取代炔基环丙化合物的制备方法 | |
| CN117683003A (zh) | 一种恩格列净中间体合成新工艺 | |
| JPS5858335B2 (ja) | アルフア − チカンアセトンノセイゾウホウ | |
| JPWO2002081451A6 (ja) | ７−キノリニル−３，５−ジヒドロキシヘプト−６−エン酸エステルの製造法 | |
| KR100530345B1 (ko) | 인듐 금속 와이어를 사용하여 니트로 화합물로부터 아민 화합물을 제조하는 방법 | |
| JP2007519660A (ja) | ２−（エトキシメチル）トロパン誘導体の製造方法 | |
| TW202216673A (zh) | 4-呋喃醯胺及製備其之方法 | |
| JPH07324072A (ja) | ３，４−ジアルキルピロール類の製造方法 | |
| JPS5934718B2 (ja) | エチルアセチレンマグネシウムハクイドの製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |